News | Focused Ultrasound Therapy | January 27, 2016

New John Grisham Book Promotes Focused Ultrasound

Best-selling author uses book to raise awareness, funds for Focused Ultrasound Foundation

John Grisham book, The Tumor, focused ultrasound

January 27, 2016 — Bestselling author John Grisham has written "The Tumor," a fictional account of how a real medical technology could impact the future of medicine. The short book is about focused ultrasound, a non-invasive therapy with the potential to transform the treatment of a variety of serious medical disorders. The Kindle e-book is available for free on Amazon.

“It’s the most important book I’ve ever written,” said Grisham. “Everyone who is concerned about their health and loved ones should read 'The Tumor' to learn about a breakthrough medical technology. I have found no other cause, issue or charity that can potentially save so many lives.”

"The Tumor" follows the experience of the fictional patient Paul, an otherwise healthy 35-year-old father who is diagnosed with a malignant brain tumor. Despite receiving current state-of-the-art treatment of invasive brain surgery, radiation and chemotherapy, he passes away nine months after his diagnosis.

Grisham then takes readers to an alternate future, where Paul is diagnosed with the same brain tumor at 35 years old in the year 2025. In this future, doctors utilize focused beams of ultrasound energy to destroy Paul’s tumor without cutting into his skull. They then refocus the ultrasound to the surrounding brain to activate nanoparticles that deliver high concentrations of chemotherapy to the brain while minimizing systemic side effects. Paul is able to go back to his busy life after these procedures. The tumor returns a couple of times, and he is retreated with the same approach. While the tumor will eventually take Paul’s life, focused ultrasound therapy could transform a fatal condition into one that is chronic, but manageable.

Focused ultrasound uses ultrasonic energy guided by real-time imaging to treat tissue deep in the body without incisions or radiation. Multiple intersecting beams of ultrasound are directed and concentrated on a target, much like a magnifying glass can focus multiple beams of light on a single point. Where each individual beam passes through the tissue, there is no effect. But, at the focal point, the convergence of the beams of focused ultrasound energy results in many important biological effects depending on the nature of the tissue and the ultrasound parameters.

“John has been a board member and steadfast supporter of our foundation for years. We are fortunate to have such a noteworthy advocate helping to spread the word about this game-changing therapy,” said Neal F. Kassell, M.D., chairman of the Focused Ultrasound Foundation. “He wants to help ensure that focused ultrasound is part of our future. Though in its infancy, there is great potential for this technology to improve quality of life and decrease cost of care. But progress is too slow, and we want to help make it available sooner to help as many people as possible.”

Grisham wrote "The Tumor" to raise awareness and funds to help the Focused Ultrasound Foundation to accelerate the development and adoption of the technology to improve the lives of millions of people with serious medical disorders. While the book is free, he encourages the public to support the foundation’s programs for research, education and advocacy.

Today, focused ultrasound is approved in the United States to treat uterine fibroids, reduce pain from bone metastases and treat the prostate. Different systems are approved to treat 16 diseases in regions around the world. The technology is in various stages of research and development for more than 50 diseases, including Parkinson’s, Alzheimer’s, hypertension and tumors of the brain, liver, breast and pancreas.

For more information: www.thetumor.org

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init